PUBLIC CONTRACT · 2017
51001417 - P259-ac-2017-10 aquisição de medicamentos desencadeada pela spms,EPE no âmbito do despacho 1571/b 2016
- Contract value
- €331,142.75
- Signed on
- 21 February 2017
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 3651822PUBLISHED SUBJECT
51001417 - P259-AC-2017-10 AQUISIÇÃO DE MEDICAMENTOS DESENCADEADA PELA SPMS,EPE NO ÂMBITO DO DESPACHO 1571/B 2016; aquisição de bevacizumab, tocilizumab, trastuzumab.
Parties involved
- Place of performance
- Portugal, Portalegre, Elvas; Portugal, Portalegre, Portalegre
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ROCHE Farmacêutica Quimica, Lda · Tax ID 500233810
Values and timeline
- Contract price
- €331,142.75
- Procedure base price
- €345,298.15
- Total effective price
- €293,913.92
- Publication date
- 5 September 2017
- Award date
- 31 January 2017
- Signing date
- 21 February 2017
- Performance period
- 120 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- CP 2015/6 - Acordo quadro para o fornecimento de Medicamentos do Foro Oncológico
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2694280
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.